Inventor of 4-disease drug gets a boost thanks to ISRAEL21c
ISRAEL21c article on David Naor’s peptide drew a $5k investment and many reader inquiries. An Israeli biotech company is planning clinical studies.
ISRAEL21c article on David Naor’s peptide drew a $5k investment and many reader inquiries. An Israeli biotech company is planning clinical studies.
Israeli expert is experimenting with intestinal parasites to fight conditions such as rheumatoid arthritis and Crohn’s disease.